These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7396752)

  • 21. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Histological types of 876 breast cancers according to the 1981 WHO classification].
    Trojani M; de Mascarel I; Coindre JM; Goussot JF; Abadjian G; Durand M; Bonichon F
    Bull Cancer; 1984; 71(1):65-9. PubMed ID: 6324935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The evaluation of the sentinel lymph nodes status in breast carcinoma using microscopic, immunohistochemical and cytomorphometric methods in order to establish new stadializations and therapeutic schemes.
    Stolnicu S; Coros MF; Podeanu DM; Carata E; Mezei T; Muscă S; Podoleanu C; Rădulescu D
    Rom J Morphol Embryol; 2009; 50(1):51-60. PubMed ID: 19221645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occult micrometastases in axillary lymph nodes predict subsequent distant metastases in stage I breast cancer: a case-control study with 15-year follow-up.
    Susnik B; Frkovic-Grazio S; Bracko M
    Ann Surg Oncol; 2004 Jun; 11(6):568-72. PubMed ID: 15150071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.
    Poller DN; Silverstein MJ; Galea M; Locker AP; Elston CW; Blamey RW; Ellis IO
    Mod Pathol; 1994 Feb; 7(2):257-62. PubMed ID: 7911998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Histological classification of stomach cancer and its prognostic value].
    Kraevskiĭ NA; Rottenberg VI
    Arkh Patol; 1979; 41(6):10-6. PubMed ID: 464832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of periodic acid-Schiff-positive patterns in primary breast cancer and its lymph node metastases.
    Buijs JT; Cleton AM; Smit VT; Löwik CW; E Papapoulos S; Pluijm Gv
    Breast Cancer Res Treat; 2004 Mar; 84(2):117-30. PubMed ID: 14999142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of prognostic significance of histological grade in node-negative invasive breast carcinoma.
    Younes M; Laucirica R
    Clin Cancer Res; 1997 Apr; 3(4):601-4. PubMed ID: 9815726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between prognostic factors of breast cancer and thyroid disorders in Turkish women.
    Cengiz O; Bozkurt B; Unal B; Yildirim O; Karabeyoglu M; Eroglu A; Koçer B; Ulaş M
    J Surg Oncol; 2004 Jul; 87(1):19-25. PubMed ID: 15221915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The World Health Organization. Histological typing of breast tumors.
    Neoplasma; 1983; 30(1):113-23. PubMed ID: 6300707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic strategies for breast cancer based on histological type.
    Akiyama F; Horii R
    Breast Cancer; 2009; 16(3):168-72. PubMed ID: 19479319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of cathepsin-D expression in female breast cancer.
    Aaltonen M; Lipponen P; Kosma VM; Aaltomaa S; Syrjänen K
    Anticancer Res; 1995; 15(3):1033-7. PubMed ID: 7645922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pathology of low-grade adenosquamous carcinoma of the breast. An immunohistochemical study.
    Drudis T; Arroyo C; Van Hoeven K; Cordon-Cardo C; Rosen PP
    Pathol Annu; 1994; 29 ( Pt 2)():181-97. PubMed ID: 7936747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast cancer prognosis. III. Prognostic factors in patients with distant metastases (M1) at the time of diagnosis.
    Rudan I; Skorić T; Rudan N
    Acta Med Croatica; 1994; 48(4-5):171-4. PubMed ID: 7534519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two techniques for measuring invasion in solid tumors. Evaluated in a retrospective study of 73 cases of breast carcinoma with 10-year follow-up.
    Laroye GJ; Panzarella T
    APMIS; 1994 Feb; 102(2):103-11. PubMed ID: 8167005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
    Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Luteinizing hormone receptor status and clinical, pathologic, and prognostic features in patients with breast carcinomas.
    Meduri G; Charnaux N; Spyratos F; Hacene K; Loosfelt H; Milgrom E
    Cancer; 2003 Apr; 97(7):1810-6. PubMed ID: 12655539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic differences of World Health Organization-assessed mitotic activity index and mitotic impression by quick scanning in invasive ductal breast cancer patients younger than 55 years.
    Skaland I; van Diest PJ; Janssen EA; Gudlaugsson E; Baak JP
    Hum Pathol; 2008 Apr; 39(4):584-90. PubMed ID: 18291440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
    Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
    Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.